CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
12 oct. 2020 02h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
12 oct. 2020 02h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...
Global Prostate Cancer Treatment Market Is Expected to Reach USD 10.67 billion by 2027 : Fior Markets
01 oct. 2020 13h00 HE
|
Fior Markets
Newark, NJ, Oct. 01, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global prostate cancer treatment market is expected to grow from USD 7.22 billion in 2019 and to reach...
CLS Americas Highlights High-Precision, Image-Guided Laser Ablation System for Prostate Tumours and Soft Tissues at FOCAL2020 Virtual Conference
29 sept. 2020 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced it will be participating in the...
CLS Americas Highlights High-Precision, Image-Guided Laser Ablation System for Prostate Tumors and Soft Tissues at FOCAL2020 Virtual Conference
29 sept. 2020 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced it will be participating in...
CLS Conducts In-Vivo Laser Ablation Studies for Neuro and Prostate using TRANBERG Thermal Therapy System with Thermoguide
22 mai 2020 04h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, May 22, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it is conducting new in-vivo precision laser ablation treatment...
CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator
29 avr. 2020 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, April 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it was granted a new U.S. Patent valid until 2036 covering its...
Prostate Cancer Treatment Market Revenue to Hit $9,904 Million By 2026
24 mars 2020 07h30 HE
|
Big Market Research
Portland, OR, March 24, 2020 (GLOBE NEWSWIRE) -- Big Market Research offers an extensive research report delivering detailed insights and growth outlook of the global prostate cancer treatment...
Desert Medical Imaging Doctors Presented Interim Clinical Study Results of MR-guided FLA Treatment of MR-visible Prostate Cancer at AdMeTech 4th Global Summit
08 oct. 2019 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) today announced that Bernadette M. Greenwood, BSc, PG Cert., RT(R)(MR) and John F. Feller, M.D. of Desert...
CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
25 mars 2019 03h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced that clinical studies and results for its imILT® heat-induced cancer immunotherapy for...